Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population.

Sinno AK, Saraiya M, Thompson TD, Hernandez BY, Goodman MT, Steinau M, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Watson M, Lyu C, Unger ER.

Obstet Gynecol. 2014 Apr;123(4):817-21. doi: 10.1097/AOG.0000000000000171.

2.

Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma.

Larsson GL, Helenius G, Andersson S, Sorbe B, Karlsson MG.

Gynecol Oncol. 2013 May;129(2):406-11. doi: 10.1016/j.ygyno.2013.02.004. Epub 2013 Feb 8.

PMID:
23402906
3.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

4.

Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina.

Alonso I, Felix A, Torné A, Fusté V, del Pino M, Castillo P, Balasch J, Pahisa J, Rios J, Ordi J.

Gynecol Oncol. 2012 Apr;125(1):194-9. doi: 10.1016/j.ygyno.2011.12.449. Epub 2012 Jan 4.

PMID:
22226684
5.

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX; HPV VVAP study group.

Eur J Cancer. 2014 Nov;50(16):2846-54. doi: 10.1016/j.ejca.2014.07.018. Epub 2014 Aug 21.

PMID:
25155250
6.

Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.

Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM.

Obstet Gynecol. 2009 Apr;113(4):917-24. doi: 10.1097/AOG.0b013e31819bd6e0. Review.

PMID:
19305339
7.

The prognostic role of human papillomavirus in patients with vaginal cancer.

Brunner AH, Grimm C, Polterauer S, Hefler L, Stani J, Heinze G, Horvat R.

Int J Gynecol Cancer. 2011 Jul;21(5):923-9. doi: 10.1097/IGC.0b013e31821bc615.

PMID:
21666483
8.

Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.

Eur J Cancer. 2015 Sep;51(13):1732-41. doi: 10.1016/j.ejca.2015.06.001. Epub 2015 Jun 26.

PMID:
26121913
9.

Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.

Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK.

PLoS One. 2014 Feb 5;9(2):e88323. doi: 10.1371/journal.pone.0088323. eCollection 2014.

10.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
11.

Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues.

Mills A, Balasubramaniam R, Longacre TA, Kong CS, Pinsky BA.

Arch Pathol Lab Med. 2013 Jan;137(1):50-4. doi: 10.5858/arpa.2011-0392-OA.

PMID:
23276174
12.

Prognostic value of human papillomavirus in anal squamous cell carcinoma.

Ravenda PS, Magni E, Botteri E, Manzotti M, Barberis M, Vacirca D, Trovato CM, Dell'Acqua V, Leonardi MC, Sideri M, Fazio N, Zampino MG.

Cancer Chemother Pharmacol. 2014 Nov;74(5):1033-8. doi: 10.1007/s00280-014-2582-x. Epub 2014 Sep 11.

PMID:
25209946
13.

A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.

Insinga RP, Liaw KL, Johnson LG, Madeleine MM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1611-22. doi: 10.1158/1055-9965.EPI-07-2922. Review.

14.

Human papillomavirus genotype distribution in tonsil cancers.

St Guily JL, Clavel C, Okaïs C, Prétet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Léocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C.

Head Neck Oncol. 2011 Feb 7;3(1):6. doi: 10.1186/1758-3284-3-6.

15.

HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.

Hammer A, Mejlgaard E, Gravitt P, Høgdall E, Christiansen P, Steiniche T, Blaakaer J.

Acta Obstet Gynecol Scand. 2015 Nov;94(11):1262-8. doi: 10.1111/aogs.12731. Epub 2015 Sep 12.

PMID:
26300424
16.

Human papillomavirus in vaginal intraepithelial neoplasia.

Chao A, Chen TC, Hsueh C, Huang CC, Yang JE, Hsueh S, Huang HJ, Lin CT, Tang YH, Liou JD, Chang CJ, Chou HH, Lai CH.

Int J Cancer. 2012 Aug 1;131(3):E259-68. doi: 10.1002/ijc.27354. Epub 2011 Dec 14.

17.

There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains.

Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L, Chauhan SC.

Gynecol Oncol. 2007 Nov;107(2):236-41. Epub 2007 Jul 30.

18.

HPV genotypes in invasive cervical cancer in Danish women.

Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D, Schledermann D.

Acta Obstet Gynecol Scand. 2013 Sep;92(9):1023-31. doi: 10.1111/aogs.12197. Epub 2013 Jul 23.

PMID:
23763577
19.

Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.

Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andújar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Muñoz N, Bosch FX, de Sanjosé S; Spanish study group RIS HPV TT.

Gynecol Oncol. 2012 Mar;124(3):512-7. doi: 10.1016/j.ygyno.2011.11.024. Epub 2011 Nov 23.

PMID:
22119990
20.

A population-based study of squamous cell vaginal cancer: HPV and cofactors.

Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H.

Gynecol Oncol. 2002 Feb;84(2):263-70.

PMID:
11812085

Supplemental Content

Support Center